Page 1 of 8

Merck and Schering just launched Saphris, a new atypical antipsychotic for Bipolar I disorder and schizophrenia.

You can see the 8-page launch ad to healthcare professionals on AdPharm.

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

Now approved
For acute and maintenance treatment of schizophrenia
Rethink the way you treat

New Once-Monthly Invega Sustenna

Brand name: Invega Sustenna
Generic name/category: paliperidone palmitate, atypical antipsychotic
Company: Janssen
Country/Market: USA, North America
Indication(s)/use: acute and maintenance treatment of schizophrenia in adults
Target: Healthcare Professionals (HCP)
Tagline: Rethink the way you treat
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric Services – November 2009

To see all of this brand's ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009

To see all of this brand’s ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

Click on thumbnail to view the full-size ad on AdPharm

She couldn’t imagine her future without depression. But we can.

Generic name/category: Corporate communications
Company: Wyeth Neuroscience
Country/Market: USA, North America
Indication(s)/use: Neurodegeneration, Pain, Schizophrenia and bipolar disorder and Depression and Anxiety
Target: Healthcare Professionals (HCP)
Tagline: Research. Education. Innovation
Medium: Print ad
Size/duration: single-page
Publication/Aired: Managed Care – February 2008

To see all of this brand’s ads on AdPharm, click here